1st Quarter - Report

THE PETRIZZO GROUP, INC. for IBIO, INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY22 funding for advanced manufacturing technologies that utilize agricultural cell line development.

LobbyistCovered position, as disclosed
MEGAN CRISTINA PEREZ BURKE —
TJ PETRIZZO —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Medical/Disease Research/Clinical Labs MED

Advance iBio as the leader in plant-made pharmaceutical manufacturing and collaboration between the U.S. Government for research and manufacturing including funding for facilitation of domestic vaccine manufacturers that utilize agricultural cell line development for virus like particle based vaccines.

LobbyistCovered position, as disclosed
MEGAN CRISTINA PEREZ BURKE Legislative Director & Director Health Policy, Congresswoman Cathy McMorris Rodgers
TJ PETRIZZO —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Health Issues HCR

Advance iBio as the leader in plant-made pharmaceutical manufacturing and collaboration between the U.S. Government for research and manufacturing including funding for facilitation of domestic vaccine manufacturers that utilize agricultural cell line development for virus like particle based vaccines.

LobbyistCovered position, as disclosed
MEGAN CRISTINA PEREZ BURKE Legislative Director & Health Policy Director, Congresswoman Cathy McMorris Rodgers
TJ PETRIZZO —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.